Copper-binding tripeptide (cosmetic and healing research)
Copper peptide GHK
A copper peptide studied for wound healing, collagen support, and hair follicle biology with mixed human evidence.
- Evidence:
- Limited human evidence
- Status:
- Not FDA-approved
- Reviewed:
- 2026-08-03
Also known as: Copper peptide GHK, Copper tripeptide-1
What is Copper peptide GHK?
A copper peptide studied for wound healing, collagen support, and hair follicle biology with mixed human evidence.
This profile is educational. It organizes publicly discussed research context for Copper peptide GHK and related naming aliases — it is not a treatment guide.
Proposed mechanism
Copper delivery modulates lysyl oxidase, collagen synthesis, antioxidant enzymes, and gene expression related to tissue remodeling.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Limited human evidence
Preclinical evidence grade: Moderate human evidence
GHK-Cu appears in dermatology and hair research for collagen remodeling and follicle support. Topical cosmetic evidence is moderate; systemic injectable use lacks robust trials. Researchers have studied its anti-inflammatory and wound-healing properties in vitro and in animals. Human evidence varies by route and indication.
Key uncertainties
- Systemic vs topical efficacy
- Hair regrowth magnitude in humans
Research areas being studied
- Wound healing
- Skin aging
- Hair follicle research
- Anti-inflammatory signaling
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Topical irritation possible
- Systemic effects poorly documented
Additional risks & considerations
- Copper toxicity at excessive exposure
- Product quality variability
- Limited injectable human data
Regulatory status
Not FDA-approved
Used in cosmetics; injectable forms not FDA approved as drugs.
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Copper peptide GHK?
A copper peptide studied for wound healing, collagen support, and hair follicle biology with mixed human evidence.
How does Copper peptide GHK work (proposed mechanism)?
Copper delivery modulates lysyl oxidase, collagen synthesis, antioxidant enzymes, and gene expression related to tissue remodeling.
What is Copper peptide GHK being researched for?
Copper peptide GHK has been discussed in research contexts including: Wound healing, Skin aging, Hair follicle research, Anti-inflammatory signaling.
What does current evidence say about Copper peptide GHK?
Limited human evidence. GHK-Cu appears in dermatology and hair research for collagen remodeling and follicle support. Topical cosmetic evidence is moderate; systemic injectable use lacks robust trials. Researchers have studied its anti-inflammatory and wound-healing properties in vitro and in animals. Human evidence varies by route and indication.
What safety considerations are noted for Copper peptide GHK?
Reported or discussed considerations include: Topical irritation possible; Systemic effects poorly documented; Copper toxicity at excessive exposure; Product quality variability; Limited injectable human data. This is educational information, not medical advice.
Is Copper peptide GHK FDA approved?
Not FDA-approved. Used in cosmetics; injectable forms not FDA approved as drugs.
References & sources
- Pickart L et al. (2015). Regenerative and protective actions of the GHK-Cu peptide — Biochim Biophys Acta. Evidence type: review.
Prefer interactive tools? Open the PepGuide library entry for Copper peptide GHK or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.